All News
Filter News
Found 809,002 articles
-
Is This Beaten-Down Marijuana Stock (Finally) A Buy?
6/6/2017
-
Aileron Therapeutics Files For $69 Million IPO As New Offerings Heat Up
6/6/2017
-
Novan Lays Off 20% of Workforce, Switches Up C-Suite
6/6/2017
-
Acorda Jumps as Parkinson’s Drug Performs Well in Late-Stage Study
6/6/2017
-
Perrigo CEO to Retire After Only 14 Months on the Job
6/6/2017
-
Genentech’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech Shares Jump
6/6/2017
-
Alkermes Release: FDA Approves Two-Month ARISTADA For Treatment Of Schizophrenia
6/6/2017
-
Biotech Entrepreneur Westphal Resigns From Flex Pharma, His 6th CEO Role
6/6/2017
-
3 Biotechs That Could Produce Explosive Gains For Risky Investors
6/6/2017
-
Avoid These 3 Networking Mistakes Every Unemployed Scientist Makes
6/6/2017
-
Cambridge's 30-Person Cure Forward to Dissolve This Week
6/6/2017
-
Israel's Struggling BioBlast Pharma Seeks Strategic Alternatives Including Partnership And Possible M&A
6/6/2017
-
Hutchison China MediTech (Chi-Med) Highlights Phase III Fruquintinib Data In Oral Presentation At ASCO
6/6/2017
-
AstraZeneca PLC Release: LYNPARZA (Olaparib) Significantly Reduces The Risk Of Disease Worsening Or Death In Patients With BRCA-Mutated Metastatic Breast Cancer
6/6/2017
-
Acorda Release: CVT-301 Phase III Data Showed Significantly Improved Motor Function During OFF Periods In Parkinson’s Disease
6/6/2017
-
ImmunoCellular Therapeutics Announces Data From ICT-121 Phase I Trial In Recurrent Glioblastoma At ASCO 2017
6/6/2017
-
eFFECTOR Presents Phase I Data On eFT508, Its Lead Product Candidate, At ASCO 2017
6/6/2017
-
Agios Presents Phase I Data From Dose-Escalation And Expansion Cohorts Of AG-120 (Ivosidenib) In Patients With IDH1 Mutant Positive Cholangiocarcinoma
6/6/2017
-
Astellas Release: Exploratory Analysis Of The Phase I/II CHRYSALIS Study Of Gilteritinib Demonstrates First Molecular Response To FLT3 Inhibitor In Acute Myeloid Leukemia
6/6/2017
-
Boston Biomedical Presents Data For Investigational Stemness Inhibitor Amcasertib At ASCO 2017
6/6/2017